Clinical Trial Update: Amifostine Plus Irinotecan in Treating Patients With Metastatic Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating amifostine plus irinotecan for metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Amifostine (amifostine)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED